RFP
RYTM icon

Root Financial Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Root Financial Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31
Closed -$2.7K – 2623
2026
Q1 		$2.7K Sell
31
-12
-28% -$1.17K ﹤0.01% 2188
2025
Q4 		$4.6K Buy
+43
New +$4.56K ﹤0.01% 1786

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Root Financial Partners's RYTM Position: Q2 2026 in Review

Root Financial Partners sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 31 shares — an estimated $2.7K sold.

Root Financial Partners first reported a position in RYTM in Q4 2025 and held it in 2 quarters. The position peaked at $4.6K in Q4 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Root Financial Partners reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 31 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $2.7K.
  • Root Financial Partners first reported a position in Rhythm Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Root Financial Partners's Rhythm Pharmaceuticals position peaked at $4.6K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.